Precisionbiotics Group Limited

University College Cork

4d Pharma Research Limited

Alimentary Health Limited

Agriculture and Food Development Authority (teagasc)

The Procter Gamble Company

Agriculture and Food Development Authority

John Francis Cryan

Eileen Frances Murphy

Timothy Dinan

Liam Diarmuid O'Mahony

Barry Kiely

Imke Elisabeth Mulder

Ted Dinan

Helene Savignac

Suaad Ahmed

Amy Beth Holt

Paul Ross

Anna Ettorre

Parthena Fotiadou

Catherine Stanton

Samantha Yuille

David Groeger

Alexander James Stevenson

Harriet Schellekens

Cristina Torres

Bernard Roy

Liam O'mahony

A strain ofAPC 1472 is described. The strain has weight lowering effects in-vivo, achieved through inducing satiety via decreased internalisation of the Ghrelin receptor, and therefore, decreased constitutive activity. Moreover, the strain also showed a trend towards decreased ghrelin receptor hypothalamic expression in HFD-fed mice when compared with vehicle control group. The strain also improves glucose tolerance and decreased insulin plasma levels in mice, indicating the strain in the prevention and/or treatment of Type II diabetes, especially in obese individuals.

for treating obesity and weight management

The invention provides a composition comprising a bacterial strain of the genus, for use in stimulating the immune system in subject.

Compositions comprising bacterial strains

The invention provides compositions comprising bacterial strains for treating and preventing central nervous system disorders and conditions.

Probioticstrain AH1714 is significantly immunomodulatory following oral consumption. The strain is useful as an immunomodulatory biotherapeutic agent.

Probioticstrain

Methods of treating a subject by administeringstrain NCIMB 41676 are discussed. The method may include orally administering a formulation comprisingstrain NCIMB 41676 to improve sleep.

NCIMB 41676

Probiotic bifidobacterium strain

Growing community of inventors

Cork, Ireland

John Francis Cryan